News from CPhI Aesica says academic partnerships are key for CMOs 06-Dec-2012 By Gareth Macdonald UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.
News from CPhI India will stamp out "fly by night operators" in trial industry, says Gov 27-Nov-2012 By Natalie Morrison The Indian Government will stamp out “fly by night operators” in its clinical trials sector by plugging "loopholes" in the regulations.
News from CPhI Single-use lets some Pharmas make own potent drugs but outsourcing demand still strong: Alkermes 22-Nov-2012 By Natalie Morrison Single-use technology will see more HP production brought in-house but contract manufacturers will still win-out, according to Alkermes.
News from CPhI Aesica ramps up HPAPI capacity to meet industry demand 07-Nov-2012 By Natalie Morrison The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is largely unmet, according to Aesica.
News from CPhI Cobra Biologics talks recent fill finish acquisition and future growth plans 25-Oct-2012 By Gareth Macdonald CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
